Works matching IS 20457634 AND DT 2020 AND VI 9 AND IP 12


Results: 37
    1
    2
    3
    4
    5
    6

    How many chronic myeloid leukemia patients who started a frontline second‐generation tyrosine kinase inhibitor have to switch to a second‐line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)

    Published in:
    Cancer Medicine, 2020, v. 9, n. 12, p. 4160, doi. 10.1002/cam4.3071
    By:
    • Breccia, Massimo;
    • Olimpieri, Pier Paolo;
    • Olimpieri, Odoardo;
    • Pane, Fabrizio;
    • Iurlo, Alessandra;
    • Foggi, Paolo;
    • Cirilli, Alessia;
    • Colatrella, Antonietta;
    • Cuomo, Marcello;
    • Gozzo, Lucia;
    • Summa, Valentina;
    • Corradini, Paolo;
    • Russo, Pierluigi
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Usefulness of <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 12, p. 4059, doi. 10.1002/cam4.3044
    By:
    • Yokose, Takahiro;
    • Kitago, Minoru;
    • Matsusaka, Yohji;
    • Masugi, Yohei;
    • Shinoda, Masahiro;
    • Yagi, Hiroshi;
    • Abe, Yuta;
    • Oshima, Go;
    • Hori, Shutaro;
    • Endo, Yutaka;
    • Toyama, Kenji;
    • Iwabuchi, Yu;
    • Takemura, Ryo;
    • Ishii, Ryota;
    • Nakahara, Tadaki;
    • Okuda, Shigeo;
    • Jinzaki, Masahiro;
    • Kitagawa, Yuko
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Issue Information.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 12, p. 4037, doi. 10.1002/cam4.2298
    Publication type:
    Article